Avidity Biosciences Inc (NASDAQ:RNA)’s traded shares stood at 1.81 million during the last session, with the company’s beta value hitting 0.90. At the close of trading, the stock’s price was $44.31, to imply an increase of 4.19% or $1.78 in intraday trading. The RNA share’s 52-week high remains $42.79, putting it 3.43% up since that peak but still an impressive 89.12% since price per share fell to its 52-week low of $4.82. The company has a valuation of $4.24B, with an average of 1.46 million shares over the past 3 months.
Avidity Biosciences Inc (NASDAQ:RNA) trade information
After registering a 4.19% upside in the last session, Avidity Biosciences Inc (RNA) has traded red over the past five days. The stock hit a weekly high of 44.67, jumping 4.19% in its intraday price action. The 5-day price performance for the stock is 19.08%, and 63.45% over 30 days. With these gigs, the year-to-date price performance is 389.61%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Avidity Biosciences Inc (RNA) estimates and forecasts
Looking at statistics comparing Avidity Biosciences Inc share performance against respective industry, we note that the company has underperformed competitors. Avidity Biosciences Inc (RNA) shares are 286.65% up over the last 6 months, with its year-to-date growth rate lower than industry average at -8.25% against 15.40%. The rating firms project that company’s revenue will grow 35.30% compared to the previous financial year.
Revenue forecast for the current quarter as set by 8 analysts is 2.64M. Meanwhile, for the current quarter, a total of 8 analyst(s) estimate revenue growth to 4.51M.Earnings reports from the last fiscal year show that sales brought in 2.14M and 1.84M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 23.40% before jumping 145.10% in the following quarter.
RNA Dividends
Avidity Biosciences Inc has its next earnings report out in August. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Avidity Biosciences Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
The next major institution holding the largest number of shares is RTW Investments LP with 7.97 shares, or about 8.33% of shares outstanding. As of the market price on Mar 31, 2024, these shares were worth $353.16 million.
